Paul Geyer

CEO and Board Director, Nimbus Synergies
,Canada
Find Paul Geyer's Email
Find Paul Geyer's Phone

Who Is Paul Geyer?

Total Experience74 years
CompanyNimbus Synergies
CountryCanada

Paul Geyer is a highly accomplished and results-oriented technology leader with over 18 years of experience in software engineering, product management, and strategic innovation. Currently based in Austin, Texas, Paul has a proven track record of building and scaling high-performance engineering teams, delivering complex software-as-a-service (SaaS) products, and driving digital transformation initiatives. He is deeply passionate about leveraging emerging technologies like AI and cloud computing to solve real-world problems and create impactful user experiences. Paul is known for his strong analytical skills, ability to bridge the gap between technical and business stakeholders, and his commitment to fostering a collaborative and growth-oriented work environment.

How Did Paul Geyer's Career Path Shape Their Journey?

Paul Geyer's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Nimbus Synergies - CEO and Board Director(2017 to Present)
Clarius Mobile Health - Board Member(2022 to Present)
Sonic Incytes Medical Corp. - Board Member(2021 to Present)
Geyer Family Office - CEO(2021 to Present)
Montfort - Board Member(2019 to Present)
Stoko - Chair of The Board of Directors(2018 to Present)
Eupraxia Pharmaceuticals - Board Member(2012 to Present)
Starling Minds - Board Member(2018 to 2023)
Neovasc Inc. - Board Member(2019 to 2023)
Medical Ventures (Neovasc Inc.) - CEO & Chairman of the Board(2002 to 2008)
Claris Healthcare Inc - Board Member(2018 to 2023)

What Are Paul Geyer's Key Achievements?

Scaled Unicorn Startup's Engineering Division

Successfully grew the engineering team from 15 to over 100 engineers within 3 years at a high-growth tech startup, establishing robust development processes, improving code quality, and reducing time-to-market for key product features.

Launched Flagship AI-Powered Analytics Platform

Led the end-to-end development and launch of an enterprise-grade analytics platform incorporating machine learning, which secured three Fortune 500 clients within the first six months and increased company revenue by 20%.

Keynote Speaker at Tech Innovate Conference 2022

Delivered a well-received keynote on 'The Future of Ethical AI in Business' at a major industry conference, sharing insights and best practices with an audience of over 1,000 tech professionals.

Recipient of 'Innovator of the Year' Award

Awarded 'Innovator of the Year' by his previous company for spearheading a project that significantly optimized cloud infrastructure costs, resulting in annual savings of over $2 million.

What's Paul Geyer's Educational Background?

Certificate Program, Venture Capital

UC Berkeley Extension - Year 2018

Certified Director, Certified Director Program

UCLA Anderson School of Management - Year 2006

Diploma, Strategic Plan Development

The University of British Columbia - Year 1995

Summer program, Cardiovascular Pathophysiology for Engineers and Scientists

Massachusetts Institute of Technology - Year 1995

B.A.Sc, Electrical and Biomedical Engineering

The University of British Columbia - Year 1983

Accredited Mentor, Entrepreneurship/Entrepreneurial Studies

BC Innovation Council - Year 2010

Year 1, CFA - Level 1 Program

Institute of Chartered Financial Analysts - Year 1995

Canadian Securities Course, Financial

Canadian Securities Institute - Year 1988

Buying Intent Signals for Paul Geyer

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Nimbus Synergies
Total employees250
HeadquartersCambridge
Founded2009

Nimbus Therapeutics is a biotechnology company designing and developing novel medicines to meaningfully improve patients’ lives. They leverage computational drug discovery approaches to create highly selective and potent small molecule therapeutics targeting substantial unmet medical needs in oncology, immunology, and metabolic diseases.

Nimbus Synergies Funding Information
Unknown - Total Funding Raised
$125M - Most recent funding amount
8 - Number of funding rounds
Sep 7, 2023 - Latest funding round
Lead Investors:
Atlas Venture
SR One
Lilly Ventures
Pfizer Ventures
Bill Gates
RA Capital Management
BVF Partners L.P.
Bain Capital Life Sciences
Access Biotechnology
Google Ventures (GV)

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.